E.l.f. Cosmetics Files For IPO, Citing ‘Disruptive’ Prestige-Value Model
This article was originally published in The Rose Sheet
Executive Summary
Positioned as a “prestige-inspired” brand of value-priced products, the eyes-lips-face brand has seen rapid growth in recent years, driven by high levels of engagement among key demographics, including Millennial and Hispanic consumers. The company filed for an IPO of up to $100m in late August.
You may also be interested in...
E.l.f. Beauty Maintains Low Prices, High Aspirations Following IPO Debut
The firm, which positions its offerings as premium-quality but sells them at value price points, is on track to book roughly 19% growth for fiscal 2016, following a smash public debut in September. The brand counts Millennials and Hispanic consumers among its most avid fans and is comfortable in every retail setting, “a true multi-channel brand.”
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.